| Name | WEE1 G2 checkpoint kinase |
| Description | This gene encodes a nuclear protein, which is a tyrosine kinase belonging to the Ser/Thr family of protein kinases. This protein catalyzes the inhibitory tyrosine phosphorylation of CDC2/cyclin B kinase, and appears to coordinate the transition between DNA replication and mitosis by protecting the nucleus from cytoplasmically activated CDC2 kinase. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nWEE1 is a serine/threonine kinase that plays a critical role in regulating cell‐cycle progression by phosphorylating and inhibiting cyclin‐dependent kinases—most notably Cdc2/CDK1—in order to delay entry into mitosis. This inhibitory action is tightly controlled: for example, WEE1 is phosphorylated by key M‐phase kinases such as polo‐like kinase 1 and Cdc2 to create phospho‐degron motifs that are recognized by the SCFβ–TrCP ubiquitin ligase complex, leading to its timely degradation. In addition, oncogenic signaling pathways, including Akt, modulate WEE1’s subcellular localization, while transcription factors like KLF2 can repress its expression in certain cancers. Aberrant expression of WEE1 has also been documented in hepatocellular carcinoma and pituitary adenomas, underscoring its importance in cell‐cycle control under both physiologic and pathological conditions."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in controlling the timing of mitotic entry, WEE1 is fundamental for maintaining genomic stability. Its inhibition or deregulation can lead to increased cyclin-dependent kinase activity, resulting in unscheduled replication origin firing, nucleotide pool depletion, and slower replication fork progression that culminates in DNA double-strand break formation. Moreover, WEE1 function is essential for enforcing the S-phase checkpoint and protecting stalled replication forks—in part by modulating endonucleases such as Mus81—thereby preventing catastrophic genomic instability following DNA damage."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "13"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nThe therapeutic potential of targeting WEE1 is underscored by its dysregulation in multiple malignancies. WEE1 is frequently overexpressed or aberrantly regulated in glioblastoma, melanoma, neuroblastoma, gastric cancer, and hematologic malignancies, where it enables tumor cells to tolerate DNA damage induced by replication stress or genotoxic therapies. Inhibition of WEE1 with small-molecule inhibitors such as AZD1775 (MK-1775) can abrogate the G2/M checkpoint, force cells with damaged DNA into premature mitosis, and thereby promote mitotic catastrophe and apoptosis. Furthermore, studies have revealed that synthetic lethality can be achieved by combining WEE1 inhibitors with other agents—such as ATR or Chk1 inhibitors—and that microRNAs (for example, members of the let-7 and miR-15 families) as well as other regulatory networks can modulate WEE1 expression and influence chemoresistance. Genome-wide screens and mechanistic studies in diverse tumor models lend strong support to the concept of exploiting WEE1 as a promising target in combination therapies."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "14", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional layers of regulation further refine WEE1 function in both normal and cancer cells. Natural compounds such as quercetin and 2‑methoxyestradiol, viral proteins (for example, HIV Vpr), and noncoding RNAs—including microRNAs like miR‑194 and miR‑128—can modulate WEE1 expression, stability, and localization. Such diverse regulatory inputs not only influence cell-cycle arrest and DNA damage responses but also impact tumor cell survival and therapeutic sensitivity, emphasizing the multifaceted nature of WEE1 regulation."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "35"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Nobumoto Watanabe, Harumi Arai, Yoshifumi Nishihara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0307700101"}], "href": "https://doi.org/10.1073/pnas.0307700101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15070733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15070733"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Tsutomu Masaki, Yasushi Shiratori, William Rengifo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/jhep.2003.50112"}], "href": "https://doi.org/10.1053/jhep.2003.50112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12601350"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12601350"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kazuhiro Katayama, Naoya Fujita, Takashi Tsuruo "}, {"type": "b", "children": [{"type": "t", "text": "Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.25.13.5725-5737.2005"}], "href": "https://doi.org/10.1128/MCB.25.13.5725-5737.2005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15964826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15964826"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "T Yoshida, S Tanaka, A Mogi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdh073"}], "href": "https://doi.org/10.1093/annonc/mdh073"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14760118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14760118"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Fang Wang, Yu Zhu, Yan Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208546"}], "href": "https://doi.org/10.1038/sj.onc.1208546"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15735666"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15735666"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Henriett Butz, István Likó, Sándor Czirják, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Endocrinol Metab (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/jc.2010-0581"}], "href": "https://doi.org/10.1210/jc.2010-0581"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20668041"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20668041"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Lyndsay M Murrow, Sireesha V Garimella, Tamara L Jones, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Breast Cancer Res Treat (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10549-009-0571-2"}], "href": "https://doi.org/10.1007/s10549-009-0571-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19821025"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19821025"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Osamu Hashimoto, Takato Ueno, Rina Kimura, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGF beta 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.10111"}], "href": "https://doi.org/10.1002/mc.10111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12669309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12669309"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Halfdan Beck, Viola Nähse-Kumpf, Marie Sofie Yoo Larsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.00412-12"}], "href": "https://doi.org/10.1128/MCB.00412-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22907750"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22907750"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Raquel Domínguez-Kelly, Yusé Martín, Stephane Koundrioukoff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1083/jcb.201101047"}], "href": "https://doi.org/10.1083/jcb.201101047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21859861"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21859861"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Jantine PosthumaDeBoer, Thomas Würdinger, Harm C A Graat, et al. "}, {"type": "b", "children": [{"type": "t", "text": "WEE1 inhibition sensitizes osteosarcoma to radiotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-11-156"}], "href": "https://doi.org/10.1186/1471-2407-11-156"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21529352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21529352"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Amirali B Bukhari, Cody W Lewis, Joanna J Pearce, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI122622"}], "href": "https://doi.org/10.1172/JCI122622"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30645202"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30645202"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Shruti Lal, Richard A Burkhart, Neil Beeharry, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HuR posttranscriptionally regulates WEE1: implications for the DNA damage response in pancreatic cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-13-1915"}], "href": "https://doi.org/10.1158/0008-5472.CAN-13-1915"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24536047"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24536047"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shahryar E Mir, Philip C De Witt Hamer, Przemek M Krawczyk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2010.08.011"}], "href": "https://doi.org/10.1016/j.ccr.2010.08.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20832752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20832752"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Sophia X Pfister, Enni Markkanen, Yanyan Jiang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccell.2015.09.015"}], "href": "https://doi.org/10.1016/j.ccell.2015.09.015"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26602815"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26602815"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-020-00959-2"}], "href": "https://doi.org/10.1186/s13045-020-00959-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32958072"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32958072"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Gry Irene Magnussen, Ruth Holm, Elisabeth Emilsen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0038254"}], "href": "https://doi.org/10.1371/journal.pone.0038254"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22719872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22719872"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Aster Legesse-Miller, Olivier Elemento, Sarah J Pfau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "let-7 Overexpression leads to an increased fraction of cells in G2/M, direct down-regulation of Cdc34, and stabilization of Wee1 kinase in primary fibroblasts."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.C900002200"}], "href": "https://doi.org/10.1074/jbc.C900002200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19126550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19126550"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Lynn M Pouliot, Yu-Chi Chen, Jennifer Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-12-1400"}], "href": "https://doi.org/10.1158/0008-5472.CAN-12-1400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22942255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22942255"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "C C Porter, J Kim, S Fosmire, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/leu.2011.392"}], "href": "https://doi.org/10.1038/leu.2011.392"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22289989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22289989"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "L Lezina, N Purmessur, A V Antonov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2013.483"}], "href": "https://doi.org/10.1038/cddis.2013.483"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24336073"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24336073"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Rosaria Chilà, Alessandra Basana, Monica Lupi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.2583"}], "href": "https://doi.org/10.18632/oncotarget.2583"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25428911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25428911"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Camilla R Elbæk, Valdemaras Petrosius, Claus S Sørensen "}, {"type": "b", "children": [{"type": "t", "text": "WEE1 kinase limits CDK activities to safeguard DNA replication and mitotic entry."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mutat Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.mrfmmm.2020.111694"}], "href": "https://doi.org/10.1016/j.mrfmmm.2020.111694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32120135"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32120135"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "C Mackintosh, D J García-Domínguez, J L Ordóñez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.153"}], "href": "https://doi.org/10.1038/onc.2012.153"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22641220"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22641220"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Anne Margriet Heijink, Vincent A Blomen, Xavier Bisteau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1505283112"}], "href": "https://doi.org/10.1073/pnas.1505283112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26598692"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26598692"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Wei-Chun Hsu, Miroslav N Nenov, Alexander Shavkunov, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0117246"}], "href": "https://doi.org/10.1371/journal.pone.0117246"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25659151"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25659151"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Xin Chen, Nuobei Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of lncRNA NEAT1_2 radiosensitizes hepatocellular carcinoma cells through regulation of miR-101-3p/WEE1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11077"}], "href": "https://doi.org/10.1002/cbin.11077"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30488993"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30488993"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Yuta Kouyama, Takaaki Masuda, Atsushi Fujii, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14163"}], "href": "https://doi.org/10.1111/cas.14163"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31390121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31390121"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Laura Creevey, Jacqueline Ryan, Harry Harvey, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1476-4598-12-23"}], "href": "https://doi.org/10.1186/1476-4598-12-23"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23531080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23531080"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Hye-Young Kim, Yunhee Cho, HyeokGu Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Targeting the WEE1 kinase as a molecular targeted therapy for gastric cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.10231"}], "href": "https://doi.org/10.18632/oncotarget.10231"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27363019"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27363019"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Qi Wang, Yaokun Chen, Haijun Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Quercetin radiosensitizes non-small cell lung cancer cells through the regulation of miR-16-5p/WEE1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "IUBMB Life (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/iub.2242"}], "href": "https://doi.org/10.1002/iub.2242"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32027086"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32027086"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Pei Li, Yang Yang, Hui Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-194 functions as a tumor suppressor in laryngeal squamous cell carcinoma by targeting Wee1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-017-0402-6"}], "href": "https://doi.org/10.1186/s13045-017-0402-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28122647"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28122647"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Archie N Tse, Tahir N Sheikh, Ho Alan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.108.050807"}], "href": "https://doi.org/10.1124/mol.108.050807"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18820127"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18820127"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Huidong Yuan, Yi-Ming Xie, Irvin S Y Chen "}, {"type": "b", "children": [{"type": "t", "text": "Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/jvi.77.3.2063-2070.2003"}], "href": "https://doi.org/10.1128/jvi.77.3.2063-2070.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12525641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12525641"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Gibanananda Ray, Gopal Dhar, Peter J Van Veldhuizen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of cell-cycle regulatory signaling network by 2-methoxyestradiol in prostate cancer cells is mediated through multiple signal transduction pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochemistry (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1021/bi051570k"}], "href": "https://doi.org/10.1021/bi051570k"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16533053"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16533053"}]}]}]}
|
| Synonyms | WEE1A, WEE1HU |
| Proteins | WEE1_HUMAN |
| NCBI Gene ID | 7465 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
WEE1 has 12,149 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 139 datasets.
Click the + buttons to view associations for WEE1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by WEE1 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of WEE1 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of WEE1 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of WEE1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of WEE1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of WEE1 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of WEE1 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| Biocarta Pathways | pathways involving WEE1 protein from the Biocarta Pathways dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of WEE1 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of WEE1 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of WEE1 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of WEE1 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of WEE1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of WEE1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with WEE1 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with WEE1 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with WEE1 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of WEE1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of WEE1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of WEE1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of WEE1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| CM4AI U2OS Cell Map Protein Localization Assemblies | assemblies containing WEE1 protein from integrated AP-MS and IF data from the CM4AI U2OS Cell Map Protein Localization Assemblies dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of WEE1 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing WEE1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing WEE1 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with WEE1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with WEE1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing WEE1 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of WEE1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with WEE1 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with WEE1 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with WEE1 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| DeepCoverMOA Drug Mechanisms of Action | small molecule perturbations with high or low expression of WEE1 protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset. | |
| DGIdb Drug Targets 2026 | interacting drugs for WEE1 protein from the DGIdb Drug Targets 2026 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with WEE1 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with WEE1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with WEE1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with WEE1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with WEE1 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| DrugBank Drug Targets | interacting drugs for WEE1 protein from the curated DrugBank Drug Targets dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at WEE1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of WEE1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of WEE1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing WEE1 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with WEE1 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with WEE1 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of WEE1 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with WEE1 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing WEE1 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of WEE1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of WEE1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of WEE1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of WEE1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of WEE1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of WEE1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving WEE1 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving WEE1 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving WEE1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing WEE1 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing WEE1 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing WEE1 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by WEE1 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by WEE1 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by WEE1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of WEE1 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of WEE1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of WEE1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of WEE1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with WEE1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of WEE1 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for WEE1 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of WEE1 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of WEE1 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of WEE1 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of WEE1 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for WEE1 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with WEE1 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| IMPC Knockout Mouse Phenotypes | phenotypes of mice caused by WEE1 gene knockout from the IMPC Knockout Mouse Phenotypes dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for WEE1 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of WEE1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of WEE1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of WEE1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEA Substrates of Kinases | kinases that phosphorylate WEE1 protein from the curated KEA Substrates of Kinases dataset. | |
| KEGG Pathways | pathways involving WEE1 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving WEE1 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate WEE1 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Kinase Library Tyrosine Kinome Atlas | kinases that phosphorylate WEE1 protein from the Kinase Library Tyrosine Kinome Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of WEE1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of WEE1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with WEE1 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of WEE1 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS Kinativ Kinase Inhibitor Bioactivity Profiles | chemical bioactivity profiles with high inhibition of WEE1 kinase activity from the Kinativ Kinase Inhibitor Bioactivity Profiles dataset. | |
| LINCS KinomeScan Kinase Inhibitor Targets | small molecules inhibiting WEE1 kinase from the KinomeScan Kinase Inhibitor Targets dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of WEE1 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of WEE1 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of WEE1 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing WEE1 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain WEE1 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by WEE1 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting WEE1 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of WEE1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by WEE1 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of WEE1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of WEE1 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing WEE1 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for WEE1 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of WEE1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of WEE1 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving WEE1 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving WEE1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Phosphosite Textmining Biological Term Annotations | biological terms co-occuring with WEE1 protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset. | |
| PhosphoSitePlus Substrates of Kinases | kinases that phosphorylate WEE1 protein from the curated PhosphoSitePlus Substrates of Kinases dataset. | |
| PID Pathways | pathways involving WEE1 protein from the PID Pathways dataset. | |
| Reactome Pathways 2014 | pathways involving WEE1 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving WEE1 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of WEE1 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of WEE1 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of WEE1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of WEE1 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at WEE1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of WEE1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of WEE1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of WEE1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of WEE1 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs | drug perturbations changing phosphorylation of WEE1 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Drugs dataset. | |
| SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands | ligand (protein) perturbations changing phosphorylation of WEE1 protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset. | |
| Tabula Sapiens Gene-Cell Associations | cell types with high or low expression of WEE1 gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of WEE1 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of WEE1 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of WEE1 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of WEE1 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of WEE1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of WEE1 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of WEE1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of WEE1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with WEE1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with WEE1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| WikiPathways Pathways 2014 | pathways involving WEE1 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving WEE1 protein from the WikiPathways Pathways 2024 dataset. | |